In this video, Dr. Kathryn Hahn discusses whether the genetic makeup of an individual influences the patient's vulnerability to an opioid use disorder.

In this video, Dr. Kenneth Kirsh discusses the four domains to consider for assessing pain outcomes.

In this video, Dr. Lynn Webster discusses some tools that clinicians can administer that are short and easy to use that are also helpful in predicting opioid use disorders.

Dr. Heit discusses if UDT can be used to confirm diagnosis of drug addiction or physical dependence.

Dr. Peppin discusses how to assess analgesia in patients with cognitive impairment or limited ability to communicate.

Dr. Carr discusses his views on pain education and what he feels is needed to address affective and cognitive dimensions of pain.

Dr. Heit discusses the key steps after finding no presence of a prescribed drug in a pain patient's urine.

Dr. Reisfield discusses whether or not UDT results can be a sole indicator of adherence to prescribed opioids.

Dr. Heit discusses whether clinicians should require UDT on only those patients who are exhibiting aberrant behaviors.

Dr. Passik discusses why clinicians should incorporate UDT into their pain practice.